stella
beta
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies — Stella
Home
/
Hematologic Malignancy
/
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
View on ClinicalTrials.gov
Recruiting
Back to Hematologic Malignancy trials
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota